91971-96-9

Basic information

• Product Name: 1,2-Benzenediamine, N-[3-(diethylamino)propyl]-
• CAS NO: 91971-96-9
• Molecular Formula: C13H23N3
• Molecular Weight: 221.346
• Mol File: 91971-96-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1,2-Benzenediamine, N-[3-(diethylamino)propyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-Benzenediamine, N-[3-(diethylamino)propyl]-(91971-96-9)
• EPA Substance Registry System: 1,2-Benzenediamine, N-[3-(diethylamino)propyl]-(91971-96-9)

Safety Data

• Hazardous Substances Data: 91971-96-9(Hazardous Substances Data)

Upstream product

• 46895-63-0 N¹,N¹-diethyl-N³-(2-nitrophenyl)propane-1,3-diamine 
• 1493-27-2 ortho-nitrofluorobenzene 
• 104-78-9 diethylaminopropylamine 

Downstream Products

• 1023698-76-1 [3-(2-benzyl-benzimidazol-1-yl)-propyl]-diethyl-amine 
• 1023698-77-2 {3-[2-(2-chlorophenoxymethyl)-benzimidazol-1-yl]-propyl}-diethyl-amine 
• 1023698-82-9 diethyl-{3-[2-(2-methoxy-phenoxymethyl)-benzimidazol-1-yl]-propyl}-amine 
• 1023698-78-3 {3-[2-(3-chlorophenoxymethyl)-benzimidazol-1-yl]-propyl}-diethyl-amine 
• 1023698-73-8 diethyl-{3-[2-(2-methoxy-benzyl)-benzimidazol-1-yl]-propyl}-amine 
• 1023698-81-8 diethyl-[3-(2-p-tolyloxymethyl-benzimidazol-1-yl)-propyl]-amine 
• 1023698-79-4 diethyl-{3-[2-(4-fluorophenoxymethyl)-benzimidazol-1-yl]-propyl}-amine 
• 1023698-71-6 C₂₃H₃₂N₄ 
• 1023698-72-7 diethyl-{3-[2-(2-fluorobenzyl)-benzimidazol-1-yl]-propyl}-amine 
• 1023698-80-7 diethyl-[3-(2-phenoxymethyl-benzimidazol-1-yl)-propyl]-amine 
• 1023698-74-9 {3-[2-(4-bromobenzyl)-benzimidazol-1-yl]-propyl}-diethyl-amine 

Relevant articles and documents

Riminophenazine derivatives as potential antituberculosis agents: Synthesis, biological, and electrochemical evaluations

A series of novel riminophenazine derivatives, having ionizable alkyl substituents at N-5 and a variety of substituents on the C-3 imino nitrogen, at C-8 and on the pendant aryl group, have been designed and synthesized. Preliminary investigations into th

Parallel synthesis of a series of potentially brain penetrant aminoalkyl benzoimidazoles

Alpha7 agonists were identified via GOLD (CCDC) docking in the putative agonist binding site of an alpha7 homology model and a series of aminoalkyl benzoimidazoles was synthesised to obtain potentially brain penetrant drugs. The array was prepared startin